Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anchor Study: Y Peginterferon Alfa-2b in CHB
NCT02327416Phase 3Unknown
- Sponsor
- Tongji Hospital
- Start
- Oct 2014
- Primary completion
- Dec 2018
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02327416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327416.